My Cart

IL-23

IL-23 Product List

  • Product Category

    Kits (3)

  • Product Status

    Launched (2)In Research (1)

  • Species

    Human (3)

  • Tag

    - (3)

  • Conjugate

    - (3)

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Etoposide phosphateBMY-40481ApprovedBristol-Myers Squibb CompanyEtopophosUnited StatesLymphoma, Non-Hodgkin; Multiple Myeloma; Testicular Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hodgkin Disease; Small Cell Lung CarcinomaCheplapharm Arzneimittel Gmbh1996-05-17Lung Neoplasms; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, Follicular; Testicular Neoplasms; Lymphoma; Germinoma; Neoplasms, Gonadal Tissue; Breast Neoplasms; Lymphoma, Non-Hodgkin; Thrombocytopenia; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Myelodysplastic-Myeloproliferative Diseases; Neoplasms, Germ Cell and Embryonal; Uterine Cervical Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Ovarian Neoplasms; Kidney Neoplasms; Neutropenia; Plasmacytoma; Myelodysplastic Syndromes; Small Cell Lung Carcinoma; Hodgkin Disease; Leukemia; Myeloproliferative Disorders; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Multiple Myeloma; Central Nervous System Neoplasms; Adrenocortical Carcinoma; Neuroblastoma; Sarcoma
Details
  • Product List
  • Marketed Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland